Kristina Campton is a Dermatology physician affiliated with Albert Einstein College of Medicine. OpenAlex indexes 34 publications with 328 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
155 White Plains Road, Suite 109 East Wing
Tarrytown, NY 10591
Telephone
914-829-8200Provider last certified this registry record 21 Jan 2026.
Industry payments
27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year202566 payments
- ABBVIE INC.Program year202525 payments
- UCB, Inc.Program year202540 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
31%Kinase inhibitor22.7%Opzelura100%Part D≥81 patientsJAK inhibitor3.8%Rinvoq100%Part D≥13 patients+ 4 more classes in this area
Dermatology
18.8%Corticosteroid14.1%Triamcinolone Acetonide79%Halobetasol Propionate14%Fluocinolone Acetonide8%Part D<11 patientsAryl Hydrocarbon Receptor Agonist1.1%Vtama100%Part D<11 patients+ 5 more classes in this area
Sensory organs
16.7%Corticosteroid16.7%Clobetasol Propionate78%Betamethasone Dipropionate14%Betamethasone Diprop Augmented9%Part D≥94 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Glucagon‐Like Peptide‐1 Receptor Agonists Are Associated With Reduced Disease Severity and Pain in Hidradenitis Suppurativa: A Retrospective Study
International Journal of Dermatology
2025 - Injectable Triamcinolone Therapy for Hidradenitis Suppurativa: a Systematic Review and Treatment Recommendations
Current Dermatology Reports
2025 - Three-week infliximab dosing is associated with improved disease control in severe hidradenitis suppurativa: A retrospective study
Journal of the American Academy of Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Lipton, MD
Albert Einstein College of Medicine
Marina Konopleva, MD, PhD
Albert Einstein College of Medicine
Solomon Moshe, MD
Albert Einstein College of Medicine
Shlomo Shinnar, MD, PhD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”